CM 611 (Invokamet 150 mg / 1000 mg)
Generic Name: canagliflozin/metformin
Pill imprint CM 611 has been identified as Invokamet 150 mg / 1000 mg.
Invokamet is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Invokamet 150 mg / 1000 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- canagliflozin/metformin
- Imprint:
- CM 611
- Strength:
- 150 mg / 1000 mg
- Color:
- Purple
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Janssen Pharmaceuticals, Inc.
More about Invokamet (canagliflozin / metformin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Consumer resources
Other brands: Invokamet XR
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
